Back to search

Ireland· IE-PA-PA1142/025/001

Traxam 3 % w/w Gel

A felbinac product containing felbinac, registered in Ireland by Amdipharm Limited. The same ATC class is registered in 4 of our 19 countries.

ATC M02AA08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedTraxam 3 % w/w GelATCM02AA08REGISTER NO.IE-PA-PA1142/025/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Felbinac is registered in 4 of 19 countries.

Countries holding a registration under ATC M02AA08 (felbinac), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 1 of them publish a price we can compare per daily dose

Felbinac · ATC M02AA08

4 / 19 countries

  • Belgiumprice
  • Ireland
  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Felbinac
Manufacturer
Amdipharm Limited
Country
Ireland (IE)
ATC code
M02AA08
ATC class
Felbinac
Defined daily dose
0.15 g, T
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1142/025/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Felbinac in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All felbinac products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Thermacare Schmerzgel
  • United Kingdom (Northern Ireland) · Felbinac Mercury Pharmaceuticals, Traxam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2e017e07-4959-4f2b-8d42-632843ee6c0a
GET /v1/drugs/2e017e07-4959-4f2b-8d42-632843ee6c0a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "routes": [
    "Topical"
  ],
  "source": "hpra",
  "atc_all": [
    "M02AA",
    "M02AA08"
  ],
  "strength": null,
  "pa_number": "PA1142/025/001",
  "substances": [
    "Felbinac"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "06/10/1987",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about felbinac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.